Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 94.58% is 199% above its 5-year average of 31.66%, near the high end of its 5-year range (0.00%–100.00%).
78.54% above its 12-month average of 52.97%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 94.28%.
GROSS MARGIN
94.58%
GROSS MARGIN AVG TTM
52.97%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
31.66%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+78.54%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+198.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.32%
median of 765 covered companies
CURRENT VS SECTOR MEDIAN
+134.57%
vs the sector median at left
Milestone Pharmaceuticals Inc.
Market Cap
$96.69M
Gross Margin
94.58%
TTM Avg
52.97%
3Y Avg
0.00%
5Y Avg
31.66%
Market Cap
$93.26M
Gross Margin
10.89%
TTM Avg
14.00%
3Y Avg
13.41%
5Y Avg
13.41%
Market Cap
$102.86M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$88.48M
Gross Margin
40.32%
TTM Avg
35.69%
3Y Avg
34.43%
5Y Avg
37.90%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $96.69M | 94.58% | 52.97% | 0.00% | 31.66% |
| Conexeu Sciences Inc. (CNXU)vs › | $96.60M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.58M | 33.04% | 66.52% | 33.26% | 38.13% |
| PolyPid Ltd. (PYPD)vs › | $98.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.26M | 10.89% | 14.00% | 13.41% | 13.41% |
| Biomea Fusion, Inc. (BMEA)vs › | $92.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Equillium, Inc. (EQ)vs › | $90.73M | 0.00% | 50.00% | 75.00% | 50.00% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImmuCell Corporation (ICCC)vs › | $88.48M | 40.32% | 35.69% | 34.43% | 37.90% |
| The Joint Corp. (JYNT)vs › | $102.92M | 81.08% | 78.73% | 81.53% | 84.24% |
Gross Margin
94.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 94.28% |
| 2026-03-31 | 70.59% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | 100.00% |
| 2022-09-30 | 100.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
